Pancreatic Cancer
-
ECOG-ACRIN-EA2186
A Randomized Phase II Study of Gemcitabine and Nab- Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naive Metastatic Pancreatic Cancer (GIANT)
PI: Grant Williams, M.D. -
ETCTN-10208
A Phase I study of Anetumab Ravtansine in Combination with either Anti-PD-1 Antibody, or Anti-CTLA4 and Anti-PD-1 Antibodies or Anti-PD-1 Antibody and Gemcitabine in Mesothelin-Positive Advanced Pancreatic Adenocarcinoma
PI: Olumide Gbolahan, M.D. -
UAB1926
Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
PI: Harrison Kim, Ph.D. -
ALLIANCE A021806
Randomized Phase III study comparing up front surgery to perioperative FOLFIRINOX of resectable pancreatic cancer
PI: J Bart Rose, M.D. -
UAB1707
-
UAB2039
Irinotecan liposome injection, oxaliplatin, 5FU / leucovorin vs. nab-paclitaxel + Gem in previously untreated metastatic adenocarcinoma of the pancreas
PI: Grant Williams, M.D. -
UAB1830
Billiary
-
UAB1951
Pembro + gem/cis vs. placebo + gem/cis first line advanced or unresectable biliary tract carcinoma
PI: Olumide Gbolahan, M.D. -
ETCTN10222